Community Pharmacy England has released a series of resources to help promote the new Pharmacy First service to patients and members of the public. Community pharmacy owners and their teams are working extremely hard to get ready to provide the new Pharmacy First service from 31st January 2024. Much of this work has been focused
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for: Tegretol® (carbamazepine) 200mg and 400mg prolonged release tablets. MSN/2024/004 Tier 2 – medium impact Date of issue: 10th January 2024 Tegretol® (carbamazepine) 200mg prolonged release (PR) tablets are out of stock until mid-January 2024. Once back in stock, supplies can support
Read moreDate issued: 3 January 2024 The Food Standards Agency has issued a company-led medicines recall for: Nutramigen® LGG Stage 1 & 2 Hypoallergenic Formula – Reckitt Benckiser Healthcare (UK) Ltd Company name: Reckitt Benckiser Healthcare (UK) Ltd Product name: Nutramigen® LGG Stage 1 & 2 Hypoallergenic Formula Batch number/expiry Product name Batch number Expiry date
Read moreTo avoid any delays in payment for electronic prescriptions dispensed in December (Dispense Notification messages submitted by 31 December 2023), pharmacy owners are reminded to submit their corresponding electronic Claim Notification (CN) messages or Electronic Reimbursement Endorsement Messages (EREMs) no later than the 5 January 2024. However, with New Year’s Day (1 January 2024) occurring
Read moreClass 4 Medicines Defect Information: Cozaar® 100mg film-coated tablets (Quadrant Pharmaceuticals Ltd) Drug alert number: EL (24)A/01 Date issued: 04 January 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Cozaar® 100mg film-coated tablets (Quadrant Pharmaceuticals Ltd) Company name: Quadrant Pharmaceuticals Ltd Product name: Cozaar®
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for: Isosorbide mononitrate (Isotard® 40XL) 40mg modified-release (MR) tablets Isosorbide mononitrate (Zemon® 40 XL) 40mg modified-release (MR) tablets Isosorbide mononitrate (Nyzamac® SR) 40mg modified-release (MR) capsules MSN/2024/001 Tier 2 – medium impact Date of issue: 3rd January 2024 Zemon® 40 XL tablets
Read moreThe Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Clarithromycin 125mg/5ml oral suspension is now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP053 for Clarithromycin 125mg/5ml oral suspension expires at 23.59pm on Friday 12 January 2024. After this date, any prescriptions for Clarithromycin 125mg/5ml oral
Read moreCommunity Pharmacy England will be hosting a webinar on Drug Tariff Category M and retained margin on Tuesday 23rd January at 7pm. While changes to Category M prices are intended to ensure delivery of the agreed retained margin of £800m to the community pharmacy sector, the system is complex and the impact on individual pharmacies
Read moreCommunity pharmacy owners are being asked to share their views on preparations for Pharmacy First, ahead of the next full Community Pharmacy England Committee meeting at the end of January. This committee meeting comes at a pivotal moment as the new national Pharmacy First service is due to launch against a backdrop of consolidations and
Read moreFollowing discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (19/01/2024) announced the following initial list of price concessions for January 2024. Please note: We are still in discussion with DHSC on a number other medicines affected by
Read more
